11-822820-C-CTCTCT
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_020376.4(PNPLA2):c.696+215_696+216insCTCTT variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000030 ( 0 hom., cov: 0)
Consequence
PNPLA2
NM_020376.4 intron
NM_020376.4 intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.77
Publications
2 publications found
Genes affected
PNPLA2 (HGNC:30802): (patatin like phospholipase domain containing 2) This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy. [provided by RefSeq, Jul 2010]
PNPLA2 Gene-Disease associations (from GenCC):
- neutral lipid storage myopathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020376.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PNPLA2 | TSL:1 MANE Select | c.696+214_696+215insTCTCT | intron | N/A | ENSP00000337701.4 | Q96AD5-1 | |||
| PNPLA2 | c.1080+214_1080+215insTCTCT | intron | N/A | ENSP00000539342.1 | |||||
| PNPLA2 | c.696+214_696+215insTCTCT | intron | N/A | ENSP00000539343.1 |
Frequencies
GnomAD3 genomes AF: 0.0000304 AC: 4AN: 131480Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
4
AN:
131480
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0000304 AC: 4AN: 131480Hom.: 0 Cov.: 0 AF XY: 0.0000483 AC XY: 3AN XY: 62072 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
AF:
AC:
4
AN:
131480
Hom.:
Cov.:
0
AF XY:
AC XY:
3
AN XY:
62072
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
36330
American (AMR)
AF:
AC:
0
AN:
12590
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3282
East Asian (EAS)
AF:
AC:
0
AN:
4676
South Asian (SAS)
AF:
AC:
0
AN:
4302
European-Finnish (FIN)
AF:
AC:
0
AN:
4948
Middle Eastern (MID)
AF:
AC:
0
AN:
262
European-Non Finnish (NFE)
AF:
AC:
4
AN:
62476
Other (OTH)
AF:
AC:
0
AN:
1766
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.00215951), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.338
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.